A consortium of investors to acquire a 25% remaining stake in Kangji Medical for HKD11.17bn.

A consortium of investors, including Ming Zhong, Yinguang Shentu, Qatar Investment Authority, a sovereign wealth fund, and TPG Capital, a private equity investment firm, agreed to acquire a 25% remaining stake in Kangji Medical, a medical device company, for HKD11.17bn.